STOCK TITAN

Viemed Healthcare (NASDAQ: VMD) director granted 12,174 RSUs

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

For VIEMED HEALTHCARE, INC. (VMD), director Timothy Smokoff reported several equity compensation events. On August 19, 2026, previously granted Restricted Stock Units and Phantom Share Units vested and were exercised or settled into a total of common shares, with 3,757 common shares then returned to the company in a disposition at $8.94 per share. Separately, on August 17, 2026, he received new grants of 12,174 Restricted Stock Units and 3,043 Phantom Share Units, each convertible into an equal number of common shares and scheduled to vest on the first anniversary of the grant date. These transactions were not reported as made under a Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.
Insider Smokoff Timothy
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Units F1, F4 15,029 $0.00 $0.00
Exercise Phantom Share Units F2, F5 3,757 $0.00 $0.00
Exercise Common Shares F1 15,029 -- --
Exercise Common Shares F2 3,757 -- --
Disposition Common Shares F3 3,757 $8.94 $34K
Grant/Award Restricted Stock Units F1, F6 12,174 $0.00 $0.00
Grant/Award Phantom Share Units F7, F8 3,043 $0.00 $0.00
Holdings After Transaction: Restricted Stock Units — 12,174 shares (Direct); Phantom Share Units — 3,043 shares (Direct); Common Shares — 90,547 shares (Direct)
Footnotes (8)
  1. F1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
  2. F2. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
  3. F3. Per share value is based on the market closing price of the common shares for August 19, 2026.
  4. F4. On August 19, 2025, the reporting person was granted Restricted Stock Units which vest on August 19, 2026.
  5. F5. On August 19, 2025, the reporting person was granted Phantom Share Units which vest on August 19, 2026.
  6. F6. Restricted Stock Units (RSUs) granted to reporting person on August 17, 2026, which vest on the first anniversary of the grant date.
  7. F7. Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
  8. F8. Represents an award granted on August 17, 2026 under the Issuer's Phantom Share Plan which vests on the first anniversary of the grant date.
RSUs exercised into common shares 15,029 shares Restricted Stock Units converted into common shares on August 19, 2026
Phantom Share Units settled 3,757 units Cash-settled phantom shares settled on August 19, 2026, economically equivalent to common shares
Common shares returned to issuer 3,757 shares at $8.94 per share Disposition of common shares to Viemed Healthcare on August 19, 2026
New RSU grant 12,174 units Restricted Stock Units granted on August 17, 2026, vesting on first anniversary
New Phantom Share Unit grant 3,043 units Phantom Share Units granted on August 17, 2026, vesting on first anniversary
Total derivative exercise shares 18,786 shares Aggregate underlying shares from derivative exercises (RSUs and phantom units) reported
RSU expiration date 2027-08-17 Expiration/vesting-related date for new RSU grant reported as 2027-08-17
Phantom Share Unit expiration date 2027-08-17 Expiration/vesting-related date for new Phantom Share Unit grant reported as 2027-08-17
Restricted Stock Units financial
"Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Phantom Share Units financial
"Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan"
cash-settled phantom shares financial
"Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan"
disposition to issuer financial
"Common Shares transaction code D ... transaction_action issuer disposition"

FAQ

What insider transactions did Timothy Smokoff report for VMD on August 19, 2026?

Timothy Smokoff reported exercising RSUs and settling Phantom Share Units into common shares, then returning 3,757 shares to Viemed Healthcare in a disposition at $8.94 per share, as part of equity award vesting and settlement activity.

How many new Restricted Stock Units were granted to Timothy Smokoff by VMD in August 2026?

On August 17, 2026, Timothy Smokoff received a grant of 12,174 Restricted Stock Units. Each RSU represents a contingent right to receive one common share and vests on the first anniversary of the grant date, subject to the plan terms.

What Phantom Share Unit activity did VMD report for Timothy Smokoff in this Form 4?

Smokoff settled 3,757 Phantom Share Units granted in 2025 and received a new grant of 3,043 Phantom Share Units on August 17, 2026. Each phantom share is economically equivalent to one common share under Viemed’s Phantom Share Plan.

At what price were common shares disposed of to Viemed Healthcare (VMD) in this filing?

A total of 3,757 common shares were returned to Viemed Healthcare at $8.94 per share. The per-share value was based on the market closing price of the common shares on August 19, 2026, according to the filing footnote.

Were Timothy Smokoff’s August 2026 VMD transactions under a Rule 10b5-1 plan?

The Form 4 indicates the transactions were not reported as being made under a Rule 10b5-1 trading plan. The document-level checkbox affirming Rule 10b5-1 status was not selected for these transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Smokoff Timothy

(Last)(First)(Middle)
625 E. KALISTE SALOOM RD.

(Street)
LAFAYETTE LOUISIANA 70508

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares08/19/2026M15,029A(1)90,547D
Common Shares08/19/2026M3,757A(2)94,304D
Common Shares08/19/2026D3,757D$8.94(3)90,547D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)08/19/2026M15,029 (4) (4)Common Shares15,029$00D
Phantom Share Units(2)08/19/2026M3,757 (5) (5)Common Shares3,757$00D
Restricted Stock Units(1)08/17/2026A12,174 (6)08/17/2027Common Shares12,174$012,174D
Phantom Share Units(7)08/17/2026A3,043 (8)08/17/2027Common Shares3,043$03,043D
Explanation of Responses:
1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
2. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
3. Per share value is based on the market closing price of the common shares for August 19, 2026.
4. On August 19, 2025, the reporting person was granted Restricted Stock Units which vest on August 19, 2026.
5. On August 19, 2025, the reporting person was granted Phantom Share Units which vest on August 19, 2026.
6. Restricted Stock Units (RSUs) granted to reporting person on August 17, 2026, which vest on the first anniversary of the grant date.
7. Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
8. Represents an award granted on August 17, 2026 under the Issuer's Phantom Share Plan which vests on the first anniversary of the grant date.
Remarks:
/s/ Jesse Bergeron, Attorney-in-Fact08/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)